Construction and characterization of avian Escherichia coli cya crp mutants.
We constructed delta cya delta crp mutants of two avian septicemic Escherichia coli strains and evaluated their attenuation in virulence. The P1 phage was used to transfer cya::Tn10 from an E. coli K-12 strain into virulent avian O78 and O2 E. coli isolates. Tetracycline-resistant transductants were plated on Bochner-Maloy Medium, and tetracycline-sensitive colonies were selected, then tested by polymerase chain reaction to confirm that they had deletions of the cya gene. Deletions of crp were created by the same technique in isolates with deletions in cya. The delta cya and delta cya delta crp derivatives had slower growth rates, smaller colonies, and impaired fermentation of carbohydrates compared with their wild parents, and they did not revert. Attenuation of the mutant strains was evaluated by subcutaneous (s.c.) inoculation of day-old chicks and by intratracheal (i.t.) inoculation of 9-day-old chicks previously inoculated intranasally with infectious bronchitis virus. For the wild O78 strain and its delta cya and delta cya delta crp derivatives, the percentages of chicks that died within 6 days of s.c. injection of approximately 5 x 10(7) organisms were 100, 60, and 0, respectively. The corresponding percentages for wild-type O2 and its delta cya and delta cya delta crp mutants were 100, 70, and 20 at a dose of approximately 2 x 10(5) organisms. Following i.t. inoculation, group scores based on pathologic and bacteriologic findings were 51%, 15%, and 9% for wild, delta cya, and delta crp O78 strains (inoculum approximately 2 x 10(7) organisms) and 98%, 31%, and 11%, respectively, for the corresponding O2 strains (inoculum approximately 4 x 10(6) organisms). This study demonstrated reduced virulence and stability of the double mutant, which may useful as a live attenuated vaccine against poultry colibacillosis.
Peighambari
S M
SM
Department of Pathobiology, Ontario Veterinary College, University of Guelph, Canada.
Gyles
C L
CL
D000262:Adenylyl Cyclases / Q000235:genetics*; D000818:Animals; D016470:Bacteremia / Q000382:microbiology / Q000662:veterinary; D002645:Chickens; D018352:Coronavirus Infections / Q000150:complications / Q000662:veterinary; D017931:DNA Primers; D004926:Escherichia coli / Q000235:genetics* / Q000302:isolation & purification* / Q000472:pathogenicity; D004927:Escherichia coli Infections / Q000150:complications / Q000382:microbiology / Q000662:veterinary*; D005838:Genotype; D001351:Infectious bronchitis virus; D009154:Mutation; D016133:Polymerase Chain Reaction; D011201:Poultry Diseases / Q000382:microbiology*; D011953:Receptors, Cyclic AMP / Q000235:genetics*; D014774:Virulence
D017931:DNA Primers; D011953:Receptors, Cyclic AMP; D000262:Adenylyl Cyclases